Popular Filters
Trials for Diffuse Large B-Cell Lymphoma Patients
Mosunetuzumab + Chemotherapy for Diffuse Large B-Cell Lymphoma
Recruiting1 awardPhase 1 & 2
Portland, Oregon
This trial is testing the safety and effectiveness of a combination of a monoclonal antibody called mosunetuzumab and chemotherapy for treating patients with certain types of lymphoma. The monoclonal
Monoclonal Antibodies
SGN-35T for Lymphoma
Recruiting1 awardPhase 1
Hackensack, New Jersey
This trial is testing a new drug in adults with certain types of lymphoma that haven't responded to other treatments. The drug works by targeting a protein on cancer cells and delivering a substance that kills them. This drug has shown high selectivity against specific cancer cells and has been approved for treating lymphoma patients.
Combination Therapy for Non-Hodgkin's Lymphoma
Recruiting1 awardPhase 1 & 2
Minneapolis, Minnesota
This trial will research the effectiveness of a combination of 3 medicines (maplirpacept, glofitamab, obinutuzumab) for non-Hodgkin lymphoma, which is a cancer of the lymphatic system. Different doses of maplirpacept will be studied.
Monoclonal Antibodies
Glofitamab + Polatuzumab-R-CHP for Diffuse Large B-Cell Lymphoma
Recruiting1 awardPhase 2
Boston, Massachusetts
This trial tests a combination of drugs to treat high-risk diffuse large B-cell lymphoma in patients who have not been treated before. The drugs help the immune system attack cancer and directly kill cancer cells. The standard treatment for diffuse large B-cell lymphoma (DLBCL) includes rituximab combined with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP).
Alkylating agents
Oral Azacitidine + R-miniCHOP for Diffuse Large B-Cell Lymphoma
Recruiting1 awardPhase 2 & 3
Costa Mesa, California
This trial compares side effects & activity of azacitidine & R-miniCHOP (monoclonal antibody, prednisone, 3 chemo drugs) in 75+ newly-diagnosed DLBCL patients. Combining azacitidine & R-miniCHOP may shrink the cancer or extend time w/o symptoms/survival compared to R-miniCHOP alone.
Trials for Non-Hodgkin's Lymphoma Patients
Mosunetuzumab + Chemotherapy for Diffuse Large B-Cell Lymphoma
Recruiting1 awardPhase 1 & 2
Portland, Oregon
This trial is testing the safety and effectiveness of a combination of a monoclonal antibody called mosunetuzumab and chemotherapy for treating patients with certain types of lymphoma. The monoclonal
Monoclonal Antibodies
SGN-35T for Lymphoma
Recruiting1 awardPhase 1
Hackensack, New Jersey
This trial is testing a new drug in adults with certain types of lymphoma that haven't responded to other treatments. The drug works by targeting a protein on cancer cells and delivering a substance that kills them. This drug has shown high selectivity against specific cancer cells and has been approved for treating lymphoma patients.
Combination Therapy for Non-Hodgkin's Lymphoma
Recruiting1 awardPhase 1 & 2
Minneapolis, Minnesota
This trial will research the effectiveness of a combination of 3 medicines (maplirpacept, glofitamab, obinutuzumab) for non-Hodgkin lymphoma, which is a cancer of the lymphatic system. Different doses of maplirpacept will be studied.
Alkylating agents
Oral Azacitidine + R-miniCHOP for Diffuse Large B-Cell Lymphoma
Recruiting1 awardPhase 2 & 3
Costa Mesa, California
This trial compares side effects & activity of azacitidine & R-miniCHOP (monoclonal antibody, prednisone, 3 chemo drugs) in 75+ newly-diagnosed DLBCL patients. Combining azacitidine & R-miniCHOP may shrink the cancer or extend time w/o symptoms/survival compared to R-miniCHOP alone.
Trials With No Placebo
Mosunetuzumab + Chemotherapy for Diffuse Large B-Cell Lymphoma
Recruiting1 awardPhase 1 & 2
Portland, Oregon
This trial is testing the safety and effectiveness of a combination of a monoclonal antibody called mosunetuzumab and chemotherapy for treating patients with certain types of lymphoma. The monoclonal
Monoclonal Antibodies
SGN-35T for Lymphoma
Recruiting1 awardPhase 1
Hackensack, New Jersey
This trial is testing a new drug in adults with certain types of lymphoma that haven't responded to other treatments. The drug works by targeting a protein on cancer cells and delivering a substance that kills them. This drug has shown high selectivity against specific cancer cells and has been approved for treating lymphoma patients.
Combination Therapy for Non-Hodgkin's Lymphoma
Recruiting1 awardPhase 1 & 2
Minneapolis, Minnesota
This trial will research the effectiveness of a combination of 3 medicines (maplirpacept, glofitamab, obinutuzumab) for non-Hodgkin lymphoma, which is a cancer of the lymphatic system. Different doses of maplirpacept will be studied.
Monoclonal Antibodies
Glofitamab + Polatuzumab-R-CHP for Diffuse Large B-Cell Lymphoma
Recruiting1 awardPhase 2
Boston, Massachusetts
This trial tests a combination of drugs to treat high-risk diffuse large B-cell lymphoma in patients who have not been treated before. The drugs help the immune system attack cancer and directly kill cancer cells. The standard treatment for diffuse large B-cell lymphoma (DLBCL) includes rituximab combined with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP).
Alkylating agents
Oral Azacitidine + R-miniCHOP for Diffuse Large B-Cell Lymphoma
Recruiting1 awardPhase 2 & 3
Costa Mesa, California
This trial compares side effects & activity of azacitidine & R-miniCHOP (monoclonal antibody, prednisone, 3 chemo drugs) in 75+ newly-diagnosed DLBCL patients. Combining azacitidine & R-miniCHOP may shrink the cancer or extend time w/o symptoms/survival compared to R-miniCHOP alone.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.